Interim CFO Sankaran to exit Aug 31; Oscar Health reaffirms 2023 outlook

Oscar Health, Inc.

CFO Siddhartha Sankaran will step down as interim CFO on Aug 31, 2023 after Q2 Form 10-Q filing.
Sankaran remains on Oscar Health's board of directors after the transition.
Departure due to internationally based executive role requiring regulatory pre-approval.
Company is seeking a permanent CFO and expects to name a successor before Aug 31.
Reaffirmed full-year 2023 guidance and profitability targets as provided on Feb 9, 2023.

item 5.02 item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Siddhartha Sankaran

Interim Chief Financial Officer

OSCR · Oscar Health, Inc.

Effective: 2023-08-31
Filed: May 30, 2023, 7:59 PM ET

On May 26, 2023, Oscar Health, Inc. (the “Company”) and Siddhartha Sankaran agreed that Mr. Sankaran will conclude his role as the Company’s Interim Chief Financial Officer as of August 31, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Siddhartha Sankaran changed role as Interim Chief Financial Officer at Oscar Health, Inc..

Action: will conclude his role
Role: Interim Chief Financial Officer

Exact text from the filing

On May 26, 2023, Oscar Health, Inc. (the “Company”) and Siddhartha Sankaran agreed that Mr. Sankaran will conclude his role as the Company’s Interim Chief Financial Officer as of August 31, 2023

View on SEC.gov

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-156580

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.